MiSeqDx Cystic Fibrosis Diagnostic Assay regulatory update

Illumina said on its 4Q12 earnings call that it submitted 510(k) applications to FDA for the MiSeqDx genome sequencing system and its MiSeqDx Cystic Fibrosis Diagnostic Assay. MiSeqDx is a benchtop se...